BTIG analyst Sean Lavin raised the price target on Medtronic, Inc. (NYSE: MDT) to $100.00 (from $91.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Needham on Medtronic, Inc. (MDT): 'We believe that MDT is in the early stages of a strong product cycle'September 1, 2026 1:27 PM